A retrospective study of changes in BMD after ART initiation and its potential associations with clinical and HIV-associated characteristics
Latest Information Update: 31 Mar 2021
At a glance
- Drugs Dolutegravir (Primary) ; Efavirenz (Primary) ; Lamivudine (Primary) ; Lopinavir/ritonavir (Primary) ; Nevirapine (Primary) ; Raltegravir (Primary) ; Stavudine (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Zidovudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 31 Mar 2021 New trial record
- 01 Feb 2021 Results published in the Osteoporosis International